Bicycle Therapeutics PLC (BCYC): Depreciation & Amortization
$6.42M
Year ended 2025-12-31
$5.29M
Trailing 12 months to 2026-06-30
+20.3%
3-year compound annual growth
+38.1%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $6.42M | -10.5% | 2026-03-17, From 2025-01-01 |
| 2024-12-31 | $7.17M | +9.6% | 2026-03-17, From 2024-01-01 |
| 2023-12-31 | $6.55M | +77.4% | 2026-03-17, From 2023-01-01 |
| 2022-12-31 | $3.69M | +161.8% | 2025-02-25, From 2022-01-01 |
| 2021-12-31 | $1.41M | +10.3% | 2024-02-20, From 2021-01-01 |
| 2020-12-31 | $1.28M | +33.0% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $960.0K | +34.8% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $712.0K | +114.5% | 2021-03-11, From 2018-01-01 |
| 2017-12-31 | $332.0K | n/a | 2020-03-10, From 2017-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Bicycle Therapeutics PLC (BCYC) | 2025-12-31 | $6.42M | -10.5% |
| Assembly Biosciences, Inc. (ASMB) | 2025-12-31 | $129.0K | 0.0% |
| Viridian Therapeutics, Inc. (VRDN) | 2025-12-31 | $460.0K | -14.8% |
| Rockwell Medical, Inc. (RMTI) | 2025-12-31 | $2.19M | +0.6% |
| Spero Therapeutics, Inc. (SPRO) | 2025-12-31 | $0 | -100.0% |
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | $4.04M | +252.9% |
| Enanta Pharmaceuticals Inc (ENTA) | 2025-09-30 | $4.59M | +96.3% |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 2025-12-31 | $3.02M | -14.6% |
| Nuvation Bio Inc. (NUVB) | 2025-12-31 | $1.74M | +154.6% |
Compare BCYC, ASMB, VRDN, RMTI side by side · Screen every company in Pharmaceutical Preparations ↗